CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form changes to once a year when possible.
You can review the list of forms revising by clicking this link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...